海外の大腸癌に対する放射線療法のベスト医師 — ページ2

モハメド・マフムード・アブデルハキム博士は、カイロ大学国立がん研究所の放射線腫瘍学教授です。シェファ・アル・オルマン病院の放射線腫瘍科部長を務めています。アブデルハキム博士は、乳がん、軟部組織肉腫、婦人科腫瘍など、複雑ながんの治療を行っています。ESTROおよびESMOの会員です。

• 画像誘導小線源治療および定位放射線治療を実施。
• IMRT、VMAT、SRS、SBRTを用いて腫瘍を精密に標的化。
• 骨髄移植のための全身および全身皮膚照射を提供。
• ESMO認定を受けたルクソールのシェファ・アル・オルマン病院で診療。

ヤーコフ・ローレンス医師は、シェバ医療センターの放射線腫瘍科部長です。精密放射線治療と神経腫瘍学を専門としています。ローレンス医師は、膵臓がんの疼痛管理のための腹腔神経叢ラジオサージェリー（放射線外科）の先駆者です。専門分野における最高の名誉の一つであるFASTROの称号を保持しています。

• シェバ医療センターの消化器がんプログラムを主導。
• 脳腫瘍および神経系がんに対する定位放射線外科手術を実施。
• 個別化された放射線プロトコルに関する280以上の科学論文を執筆。
• トーマス・ジェファーソン大学で放射線腫瘍学のフェローシップ研修を修了。

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

アン・ジンソク医師は、サムスン医療センターにて大腸がんの放射線治療を専門としています。

• 大腸がん治療において豊富な経験を持つ腫瘍内科医
• がん治療の主要施設であるサムスン医療センターに勤務

サムスン医療センターの放射線治療専門の腫瘍内科医。

• 放射線を用いた大腸がん治療の経験が豊富
• 韓国の主要な医療センターに勤務
• 患者一人ひとりに合わせた治療計画に注力

Lim Do Hoon教授は、サムスン医療センターの放射線腫瘍科を統括し、消化器がんおよび希少がんを専門としています。

• ソウル大学校病院およびサムスン医療センターで研修
• 胃がん、膵胆道がん、小児腫瘍を専門
• 複雑な消化器症例に対する放射線療法の専門家
• 韓国がん協会および韓国放射線腫瘍学会の会員

Choi Du Kho医師は心臓関連の手術を専門としており、Samsung Medical Centerで以上の経験を有しています。

• ロボット支援心臓手術の専門家
• 弁修復および置換術の熟練者
• 小児心臓手術を実施

ミリアム・ベン・ハルシュ教授は、ルース・ラパポート小児病院における小児腫瘍学および骨髄移植の国際的に認められた専門家です。

• ランバム医療センター小児科部長
• レジオンドヌール勲章受章者
• 世界医師会により「世界で最も思いやりのある医師」の一人に選出
• 米国小児腫瘍学グループ会員

当医師は、がんの診断と治療を専門とする経験豊富な腫瘍内科医兼放射線科医です。高度な画像診断技術と個別化されたがん治療に重点を置き、臨床現場と研究の両面からこの分野に大きく貢献してきました。患者の転帰改善を目的とした数多くの臨床試験に携わり、査読付き医学雑誌にも多数の論文を発表しています。腫瘍学と放射線学の両方で専門医認定を受けており、最高水準の医療を提供することに尽力しています。

当医師は、がん治療のための高度な放射線療法技術を専門とする経験豊富な放射線治療医です。15年以上の臨床経験を持ち、研究や臨床試験を通じて患者の治療成績向上に大きく貢献してきました。定位放射線手術および強度変調放射線治療における専門知識が高く評価されており、最先端の医療を提供しています。査読付き論文を多数発表しており、国際的な腫瘍学会でも頻繁に講演を行っています。

タメル・アタセバー教授は、トルコのトップ機関での指導的役割を含む、34 年の核医学の専門知識を有しています。

• メディポル大学病院およびガジ大学教授
• アンカラ・オーダー研究所の元核医学部長
• 欧州核医学会会員
• 高度な診断および治療核医学を専門とする

サディル・アルラウィ博士は、認定された外科腫瘍医です。上部消化管、頭頸部、低侵襲手術、乳がん、大腸がんを専門としています。また、温熱化学療法にも精通しています。アルラウィ博士は、UAEおよびMENA地域のVPS病院システムの腫瘍学サービスディレクターを務めており、複数の三次がん紹介センターを統括しています。

アルラウィ博士は、米国および英国の専門医認定を取得しています。ロズウェルパークがん研究所でフェローシップを修了しました。以前は、アル・ザフラ病院、タワム病院（ジョンズ・ホプキンス提携）、フロリダの21st Century Oncologyで腫瘍学部門を率いていました。アルラウィ博士は多くの出版物があり、招待講演も多数行っています。腫瘍学の研究と教育に積極的に取り組んでいます。

ラージ医師は_doctor_2241_年にわたり50,000件以上の癌手術を行い、HCG Manavataがんセンターで乳房および胸部外科腫瘍学を専門としています。

• タタ記念病院およびエディンバラ王立外科医師会で研修
• 第1〜3相試験を含む200以上の臨床試験に関与
• DNB外科腫瘍学および乳房外科の教授
• 治療とともに生活の質の向上に重点を置いている

Shaunak医師は結腸直腸がんの標的療法を専門としており、米国臨床腫瘍学会（ASCO）で研究発表を行っています。

• インドラプラスタ・アポロ病院にて腫瘍内科の研修
• がんの分子基盤に関する専門知識
• ASCOにて胃がんに関する研究を発表
• ジャワハルラール・ネルーがん病院にてシニアレジデント

ラリット・バンスワル医師は、_doctor_2291_年の経験の中で10,000件以上の主要な手術を執刀しており、HCG Manavata Cancer Centreにて消化器がん治療に注力しています。

• コルカタのタタ・メディカル・センターにて外科腫瘍学のフェローシップ修了
• 優れた治療成績を誇る低侵襲がん手術の専門家
• アウランガバードの州立がん研究所および政府がん病院の元助教授
• 多数の国内外の研究論文を発表
• 患者に寄り添う倫理的なアプローチで知られる

アーマー・アリフ・シェイク医師は、HCGマナヴァタ・がんセンターにて、臓器温存と機能的リハビリテーションに重点を置いた口腔がん手術を専門としています。

• 15 年 の腫瘍外科経験
• 頭頸部腫瘍外科のフェローシップ研修修了
• 主要な顎顔面および頭頸部手術に精通
• 多数の論文を発表している研究者

シュルティ・ケイト医師は、進行がんに対する免疫療法およびメトロノミック療法を専門としており、世界肺癌会議にて研究発表を行っています。

• インド屈指のがんセンターであるタタ記念病院で研修
• 肺がん、乳がん、婦人科がん、泌尿器がんの専門知識
• ASCO、ESMOおよびその他の主要な腫瘍学会の会員
• WCLC 2018の栄誉あるトラベルアワード受賞者